However, given that differences in AR protein variant profiles in placenta and prostate cancer have been observed [8], it is likely that tissue-specific responses to androgens, and thus, changes in the direction of the regulation of AR-mediated transcripts occur. The gene discussed is AR; the disease is prostate carcinoma.